Chemotherapy for advanced pancreatic cancer - some light at the end of the tunnel? (Q61868299)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233516%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

editorial

0 references

title

Chemotherapy for advanced pancreatic cancer--some light at the end of the tunnel? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233516%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233516%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

R A Popescu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233516%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 May 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233516%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233516%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233516%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233516%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

415-416

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233516%20AND%20SRC:MED&resulttype=core&format=json

Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292224326

7 January 2021

A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292224326

7 January 2021

Should further studies of chemotherapy be carried out in pancreatic cancer?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292224326

7 January 2021

No standard treatment is available for advanced pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292224326

7 January 2021

Chemotherapy prolongs survival in inoperable pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292224326

7 January 2021

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292224326

7 January 2021

A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292224326

7 January 2021

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292224326

7 January 2021

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292224326

7 January 2021

Continuous infusion 5-fluorouracil plus weekly cisplatin for pancreatic carcinoma. A Mid-Atlantic Oncology Program study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292224326

7 January 2021

Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: A Mid-Atlantic Oncology Program study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292224326

7 January 2021

Cisplatin and protracted venous infusion 5-fluorouracil (CF)--good symptom relief with low toxicity in advanced pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008292224326

7 January 2021

Identifiers

DOI

10.1023/A:1008292224326

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9233516%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference